| scholarly article | Q13442814 |
| P2093 | author name string | Chao Zhang | |
| Peng Wu | |||
| Fang Zhang | |||
| Min Li | |||
| Wenjie Liu | |||
| Zhaokai Wang | |||
| Longhe Yang | |||
| Hu Fan | |||
| P2860 | cites work | Anti-diabetic effect of a traditional Chinese medicine formula. | Q51352693 |
| Design, synthesis and biological evaluation of 4-fluoropyrrolidine-2-carbonitrile and octahydrocyclopenta[b]pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors. | Q53462796 | ||
| Emodin ameliorates high glucose induced-podocyte epithelial-mesenchymal transition in-vitro and in-vivo. | Q53576886 | ||
| Emodin-induced inhibition of growth and DNA damage in the Helicobacter pylori | Q74173332 | ||
| Emodin protects against diabetic cardiomyopathy by regulating the AKT/GSK-3β signaling pathway in the rat model | Q85331689 | ||
| Bioassay-guided isolation of DPP-4 inhibitory fractions from extracts of submerged cultured of Inonotus obliquus | Q85906676 | ||
| Emodin, a natural product, selectively inhibits 11beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice | Q24627436 | ||
| Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV | Q27644485 | ||
| 8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes | Q27649174 | ||
| Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes | Q28262769 | ||
| Biology of incretins: GLP-1 and GIP | Q29617302 | ||
| Chinese herbal medicines for type 2 diabetes mellitus | Q31097067 | ||
| Immune reponses in human mesangial cells regulated by emodin from Polygonum hypoleucum Ohwi | Q32101822 | ||
| Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9. | Q33368655 | ||
| A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide | Q34661843 | ||
| Effect of diacerein on insulin secretion and metabolic control in drug-naive patients with type 2 diabetes: a randomized clinical trial | Q35060231 | ||
| Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. | Q35189265 | ||
| Emodin regulates glucose utilization by activating AMP-activated protein kinase | Q36635928 | ||
| Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
| Berry and Citrus Phenolic Compounds Inhibit Dipeptidyl Peptidase IV: Implications in Diabetes Management | Q37171907 | ||
| Emodin, an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob mice | Q37729480 | ||
| Diabetes is an inflammatory disease: evidence from traditional Chinese medicines | Q37825944 | ||
| Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer. | Q38130366 | ||
| The distinct mechanisms of the antitumor activity of emodin in different types of cancer (Review). | Q38142749 | ||
| Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors | Q38248682 | ||
| Astragalus polysaccharides decreased the expression of PTP1B through relieving ER stress induced activation of ATF6 in a rat model of type 2 diabetes | Q39838494 | ||
| The role of β cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs | Q41849970 | ||
| Antihyperglycemic effect of catalpol in streptozotocin-induced diabetic rats | Q43046471 | ||
| Anti-diabetic effects of emodin involved in the activation of PPARgamma on high-fat diet-fed and low dose of streptozotocin-induced diabetic mice | Q43287880 | ||
| Aloe emodin suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. | Q44036377 | ||
| 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties | Q44474559 | ||
| (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes | Q45212807 | ||
| Hypoglycaemic and hypolipidaemic effects of emodin and its effect on L-type calcium channels in dyslipidaemic-diabetic rats | Q46373869 | ||
| The protection of Rhein lysinate to liver in diabetic mice induced by high-fat diet and streptozotocin | Q46873961 | ||
| NTP Toxicology and Carcinogenesis Studies of EMODIN (CAS NO. 518-82-1) Feed Studies in F344/N Rats and B6C3F1 Mice. | Q47409195 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Rheum palmatum | Q1109580 |
| P304 | page(s) | e3283 | |
| P577 | publication date | 2017-05-10 | |
| P1433 | published in | PeerJ | Q2000010 |
| P1476 | title | Screening of a natural compound library identifies emodin, a natural compound from Rheum palmatum Linn that inhibits DPP4. | |
| P478 | volume | 5 |
| Q64226372 | Polyalthia Clerodane Diterpene Potentiates Hypoglycemia via Inhibition of Dipeptidyl Peptidase 4 |
| Q49940117 | Tackling dipeptidyl peptidase IV in neurological disorders |
| Q90291678 | The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo |
Search more.